Results

Total Results: 1,187 records

Showing results for "weeks".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
    September 01, 2014 - [-1.01 to 5.01] Mean difference at endpoint -20.00 [-85.19 to 45.19] Hindley 20046 RCT 6 weeks … (2.4)* 2/41 (4.9) NR RR [95% CI] 0.91 [0.19 to 4.26] 0.91 [0.13 to 6.18] Hindley, 20046 RCT 6 weeks … † Botulinum - transitory exacerbation of per-existing urine incontinence for 2 weeks, lidocaine -anal … sildenafil citrate and placebo patients.12 Tang et al. report substantial reductions in PVRs after 2 weeks … sildenafil citrate (n=20) NR 1/20 (0.05) NR NR NR Tang, 200613 RCT 2 weeks placebo (n=20
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
    December 01, 2011 - Peer Reviewer #5 Methods Pg. 33 line 5 “RCTs of at least 6 weeks duration and an adult study population … Peer Reviewer #5 Results KQ1 Page 91 or page 77, line 29-31 After 12 weeks of treatment, significantly
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
    September 01, 2020 - One session + supplementary session for chief investigator; 3-4 visits for GP Once a week for 4 weeks … reported as received by a parent in the past 12 months, daily use of inhaled steroids in the past 4 weeks … , and daily use of controller medications in the past 4 weeks. … 12 months, and parent report of how limited their child had been from asthma in the previous 2 weeks
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
    October 01, 2015 - of instillation regimen, classified as single instillation, induction therapy (treatment for 4 to 8 weeks … ), maintenance therapy (treatment for longer than 8 weeks), or other. … 13 • One trial of patients with higher risk NMIBC found that MMC 20 mg induction therapy for 6 weeks … Limited evidence suggested that BCG maintenance regimens (>6 weeks) are more effective than induction … regimens (≤6 weeks) at reducing risk of bladder cancer recurrence in patients with higher risk tumors
  5. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - ITCA 650 produced mean reductions in HbA1c of 1.4% at 39 weeks of treatment. … Over 39 weeks, patients who received 60 mcg/day lost a mean of 4 kg, compared with 2 kg in the placebo … ITCA 650 produced sustained mean reductions in HbA1c of 1.4% at 39 weeks of treatment (in a modified … The company announced that at 52 weeks, “ITCA 650 results were superior vs. … After 24 weeks, Afrezza plus basal insulin therapy “provided a mean reduction in HbA1c that met the
  6. effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_disposition-comments.pdf
    January 28, 2016 - While 2 weeks of gluten challenge can induce intestinal changes in many adults, a substantial proportion … We have revised to include the ACG algorithm (Rubio-Tapa, 2013) that recommends an additional six weeks … revised this section to include the ACG algorithm (Rubio-Tapa, 2013) that recommends at least two weeks … challenge before conducting biopsy, and an additional six weeks for adults who can tolerate.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
    January 01, 2020 - unchanged since the schedule was first published by the Children’s Bureau in 1930: monthly visits until 28 weeks … , every 2 weeks until 36 weeks, and weekly until delivery.10 The American College of Obstetricians and … for dating and viability and to evaluate anatomy, respectively), a diabetes screen between 24 and 28 weeks
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
    October 07, 2011 - Methods I am concerned about interpreting ‘long term’ as ’12 weeks or longer.’ … range of studies reporting on our multiple outcomes, we opted to include studies with a minimum of 12 weeks … the publication reports TC mg/dL [-1 (0.4)] for candesartan and [- 12(5.6)] for perindopril at 12 weeks
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
    June 01, 2017 - design Funding source Inclusion criteria Age range (y) Number of assessments/ followup duration (weeks … design Funding source Inclusion criteria Age range (y) Number of assessments/ followup duration (weeks … design Funding source Inclusion criteria Age range (y) Number of assessments/ followup duration (weeks … design Funding source Inclusion criteria Age range (y) Number of assessments/ followup duration (weeks … waiting for a period of nine months with analysis by intention to treat Maw 1999 10459904 TT within 6 weeks
  10. SRDR-Charter-140305 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
    June 01, 2012 - − The SRDR operational team will send out meeting minutes no later than  two weeks after the meeting
  11. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
    September 26, 2014 - The authors reported the following results:58 After 26 treatment weeks, mean glycosylated hemoglobin … Confirmed hypoglycemia rates (plasma glucose <3.1 mmol/L or severe hypoglycemia) were similar at weeks … the following results in May 2013:81 HbA1c was significantly lower in all groups after 12 and 24 weeks … Weight was reduced by 2.8-3.7 kg (P < 0.05) at 24 weeks in all except the 20→20 μg/day group. … Benefit occurred for both doses compared with sham at 3 weeks and all subsequent time points.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - The recommended initial adult dose is either 2.25 mcg/kg SC weekly or 500 mcg SC every 3 weeks. … group given Epoetin (alpha or beta) or Darbepoetin subcutaneously or intravenously for at least four weeks … Was epoetin (alfa or beta) or darbepoetin given subcutaneously or intravenously for at least four weeks
  13. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
    October 01, 2015 - orally, twice daily, had significant improvements in lung function and fewer exacerbations after 24 weeks … of patients with declining lung function or who died compared with patients given placebo after 52 weeks … smaller decline in lung function compared with lung function in patients given placebo, after 52 weeks … patients begin with one capsule (267 mg) three times daily, and titrate to the full dosage after 2 weeks … with IPF were treated with pirfenidone three times daily (for a total of 801 mg) or placebo for 52 weeks
  14. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
    January 01, 2007 - The NNT to gain one additional responder at 6 to 12 weeks with sertraline was 14 (95-percent CI, 8-22 … The NNT to gain one additional responder at 6 to 12 weeks with venlafaxine was 12 (95-percent CI, 7-50 … The NNT to yield one additional responder after 1 or 2 weeks of treatment is 7 (95-percent CI, 5-12); … after 4 weeks of treatment, however, most response rates were similar. … Mean weight gains compared to pretreatment ranged from 0.8 kg to 3.0 kg after 6 to 8 weeks of treatment
  15. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
    March 01, 2022 - Study Selection Criteria Population Adults with chronic pain (>12 weeks) Interventions Cannabinoids ( … nonpharmacologic therapy Outcome: Pain, function, satisfaction, quality of life, and adverse events (≤ 4 weeks
  16. effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
    January 01, 2018 - Tolle, 2008 Fair NPP (DPN) PGB/GBP Pregabalin 150 mg/d 12 Rebecca Jungbauer: Rebecca Jungbauer: 8 weeks … Tolle, 2008 Fair NPP (DPN) PGB/GBP Pregabalin 300 mg/d 12 Rebecca Jungbauer: Rebecca Jungbauer: 8 weeks … Tolle, 2008 Fair NPP (DPN) PGB/GBP Pregabalin 600 mg/d 12 Rebecca Jungbauer: Rebecca Jungbauer: 8 weeks … NR 7 101 NR Tolle, 2008 Fair NPP (DPN) Placebo Placebo 12 Rebecca Jungbauer: Rebecca Jungbauer: 8 weeks … , for those who recorded fewer than 7 diary entries Rebecca Jungbauer: Rebecca Jungbauer: 8 weeks, for
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
    January 01, 2020 - Are 2 weeks of daily breastfeeding support insufficient to overcome the influences of formula? … Methods RCT Intervention was 2 weeks of daily phone calls by bilingual nurse immediately after discharge … p 24, l 30: I am familiar with another study that examined # of BFHI steps and breastfeeding at 6 weeks … have met your review criteria because the outcome is described as discontinued breastfeeding at 6 weeks … rather than breastfeeding at 6 weeks but I want to mention.
  18. effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - fracture, health-related quality of life, glucose intolerance, malignancy, and mortality T — At least 4 weeks … Again, to broaden the inclusion criteria as much as possible, we were open to studies at least 4 weeks … Step 11: After 2 weeks, the topic refinement document is discussed with key informants and questions
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
    March 10, 2010 - 1149: the logic of the sentence is not clear: what is the relationship between underpowered with 24 weeks … Published Online: March 10, 2010 Section Comment Response from eligible NRS that were 24 weeks … atorvastatin 10-40 + ezetimibe vs. atorvastatin 20-80 as monotherapy for the longest follow up of 14 weeks … E-10 Participants reaching ATPIII LDL-c goals (follow-up 18 weeks), Participants with events – combination … "For the efficacy analysis, the primary analysis will be an intention-to-treat approach after 12 weeks
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
    August 01, 2021 - Methods Research Report: Creating Efficiencies in the Extraction of Data From Randomized Trials Methods Research Report Creating Efficiencies in the Extraction of Data From Randomized Trials: A Prospective Evaluation of a Machine Learning and Text Mining Tool Methods Research Report Creating Efficie…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: